https://www.ajmc.com/view/cilta-cel-leads-to-prolonged-progression-free-survival-in-multiple-myeloma
Yi Lin, MD, PhD, hematologist and oncologist, Mayo Clinic, discusses the efficacy of ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor T-cell...
progression free survivalleads tocelprolongedmultiple
https://www.gsk.com/en-gb/media/press-releases/dreamm-7-phase-iii-trial-shows-pfs-improvement-and-strong-os-trend-for-blenrep-combo-versus-soc-combo-in-multiple-myeloma/
Results from an interim analysis of the DREAMM-7 phase III head-to-head trial.
phase iii trialshowsblenrepcombinationnearly
https://fa.acteropharma.com/useful-predictors-of-progression-free-survival-for-japanese-patients-with-latitude-high-risk-metastatic-castration-sensitive-prostate-cancer-who-received-upfront-abiraterone-acetate/
progression free survivalusefuljapanesepatients
https://www.marketscreener.com/news/abbvie-genmab-lymphoma-treatment-shows-improved-progression-free-survival-ce7e58dfd88af421
By Kelly Cloonan Topline results from a trial evaluating AbbVie and Genmab's epcoritamab to treat a type of lymphoma demonstrated an improvement in...
progression free survivalabbviegenmablymphomatreatment